An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a multicenter, open-label, single-arm study of prophylaxis for Dato-DXd-related stomatitis in eligible patients with metastatic or inoperable locally recurrent breast cancer or locally advanced or metastatic Epidermal Growth Factor Receptor-Mutated (EGFRm) non-small cell lung cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie zaawansowanego raka piersi (HR+/HER2-) lub zaawansowanego raka płuc (EGFR-mutujący) niepodlegającego operacji
- •Wiek co najmniej 18 lat
- •Wcześniejsze leczenie chemioterapią i/lub terapią celowaną na nowotwór
- •Gotowość do stosowania płynu odkażającego do jamy ustnej (deksametazon) przez cały czas leczenia
- •Dobry stan ogólny (skala ECOG 0-1)
- •Wystarczająca liczba hemoglobiny we krwi (co najmniej 9 g/dL)
- •Ujemny test ciążowy dla kobiet w wieku reprodukcyjnym
- •Zdolność do podpisania świadomej zgody i przestrzegania zasad badania
✗ Disqualifies
- •Wcześniejsze otrzymanie leku Dato-DXd
- •Poważne problemy kardiologiczne, oddechowe, naczyniowe lub nerkami
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (39)
Research Site
Tucson, United States
Research Site
Hot Springs, United States
Research Site
Little Rock, United States
Research Site
Duarte, United States
Research Site
Glendale, United States
Research Site
Lakewood, United States
Research Site
Long Beach, United States
Research Site
Torrance, United States
Research Site
Washington D.C., United States
Research Site
Plantation, United States
Research Site
Athens, United States
Research Site
Boise, United States
Research Site
Park Ridge, United States
Research Site
Fort Wayne, United States
Research Site
Elizabethtown, United States
Research Site
Lexington, United States
Research Site
Lexington, United States
Research Site
Louisville, United States
Research Site
New Orleans, United States
Research Site
Frederick, United States
Research Site
Glenn Dale, United States
Research Site
Detroit, United States
Research Site
Grayling, United States
Research Site
Minneapolis, United States
Research Site
Kansas City, United States
Research Site
Reno, United States
Research Site
Lebanon, United States
Research Site
East Syracuse, United States
Research Site
Westbury, United States
Research Site
White Plains, United States
Research Site
Greensboro, United States
Research Site
Wilson, United States
Research Site
Cleveland, United States
Research Site
Wynnewood, United States
Research Site
Knoxville, United States
Research Site
Fairfax, United States
Research Site
Charleston, United States
Research Site
Morgantown, United States
Research Site
Waukesha, United States
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.